# Bavarian Nordic receives $120M contract from U.S. government for smallpox/mpox vaccine

Bavarian Nordic has received a $120 million contract from BARDA to manufacture bulk smallpox/mpox vaccine, replenishing inventory used during the 2022 mpox outbreak. The contract includes $96 million for bulk product in 2023 and additional doses and services through 2025.

- Type: Contract
- Announced: 2023-08-03
- Where: United States
- Value: $120.0M
- Status: completed
- Products: smallpox/mpox vaccine

## Companies

- [Bavarian Nordic](https://endata.com/companies/26366.md)
- [Biomedical Advanced Research and Development Authority](https://endata.com/companies/8807.md) (customer)

## Sources

- [business.sherbrookerecord.com](https://business.sherbrookerecord.com/observerreporter/article/gnwcq-2023-8-3-bavarian-nordic-receives-usd-120-million-contract-for-the-manufacturing-of-smallpox-and-mpox-vaccine-from-the-us-government), 2023-08-03: "The U.S. government's foresight enabled us last year to rapidly respond to the global mpox outbreak by converting readily available bulk product into final vaccine doses."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.